J. Roman

发表

The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cells.

T. O'brien, S. Anfossi, L. E. De Las Casas, 2004, Gynecologic oncology.

The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.

T. O'brien, L. E. De Las Casas, S. Bellone, 2004, American journal of obstetrics and gynecology.

Overexpression of Clostridium perfringens Enterotoxin Receptors Claudin-3 and Claudin-4 in Uterine Carcinosarcomas

J. McKenney, E. Siegel, S. Bellone, 2007, Clinical Cancer Research.

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.

E. Siegel, S. Bellone, A. Santin, 2005, American journal of obstetrics and gynecology.

Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer

E. Diamandis, S. Bellone, A. Santin, 2005, Clinical Cancer Research.

Current treatment options for endometrial cancer

T. O'brien, S. Bellone, A. Santin, 2004, Expert review of anticancer therapy.

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.

G. Parham, S. Bellone, A. Santin, 2002, International journal of radiation oncology, biology, physics.

Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.

G. Parham, P. Hermonat, S. Bellone, 2000, International journal of radiation oncology, biology, physics.

Induction of tumour-specific CD8+ cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer

G. Parham, S. Bellone, A. Santin, 2002, British Journal of Cancer.

The novel serine protease tumor‐associated differentially expressed gene–15 (matriptase/MT‐SP1) is highly overexpressed in cervical carcinoma

T. O'brien, S. Anfossi, L. E. De Las Casas, 2003, Cancer.

Overcoming extreme obesity with robotic surgery

A. Burnett, J. Roman, P. Stone, 2010, The international journal of medical robotics + computer assisted surgery : MRCAS.

Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy.

S. Bellone, A. Santin, S. Pecorelli, 2003, Gynecologic oncology.

Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.

S. Bellone, A. Santin, S. Pecorelli, 2003, Gynecologic oncology.

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno‐associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells

P. Hermonat, F. Grizzi, M. Chiriva-Internati, 2002, European journal of immunology.

Phenotypic and Functional Analysis of Tumor-Infiltrating Lymphocytes Compared with Tumor-Associated Lymphocytes from Ascitic Fluid and Peripheral Blood Lymphocytes in Patients with Advanced Ovarian Cancer

G. Parham, P. Hermonat, S. Bellone, 2001, Gynecologic and Obstetric Investigation.

Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer

T. O'brien, S. Bellone, A. Santin, 2004, BJOG : an international journal of obstetrics and gynaecology.

Restoration of tumor specific human leukocyte antigens class I‐restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer

S. Bellone, A. Santin, S. Pecorelli, 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Increased levels of interleukin‐10 and transforming growth factor‐β in the plasma and ascitic fluid of patients with advanced ovarian cancer

G. Parham, S. Bellone, A. Santin, 2001 .

Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.

C. V. Smith, G. Parham, S. Bellone, 2001, BJOG : an international journal of obstetrics and gynaecology.

Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.

S. Bellone, A. Santin, S. Pecorelli, 2005, Current pharmaceutical design.

Robotic radical trachelectomy for preservation of fertility in early cervical cancer: case series and description of technique.

A. Burnett, J. Roman, P. Stone, 2009, Journal of minimally invasive gynecology.

Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.

G. Parham, P. Hermonat, S. Bellone, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer

S. Bellone, A. Santin, S. Pecorelli, 2003, International Journal of Gynecologic Cancer.

Metastatic Uterine Leiomyosarcoma Regression Using an Aromatase Inhibitor

A. Santin, A. Burnett, J. Roman, 2007, Obstetrics and gynecology.

Local administration of interleukin-11 ameliorates intestinal radiation injury in rats.

M. Boerma, M. Hauer-Jensen, A. Santin, 2007, Cancer research.

Temporal acceleration of the human papillomavirus life cycle by adeno-associated virus (AAV) type 2 superinfection in natural host tissue.

P. Hermonat, M. Chiriva-Internati, N. Agrawal, 2002, Virology.

Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial

E. Siegel, S. Bellone, A. Santin, 2007, Journal of Virology.

HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.

S. Bellone, A. Santin, S. Pecorelli, 2006, Gynecologic oncology.

Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes

G. Parham, P. Hermonat, S. Bellone, 2000, Journal of virology.

Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.

Erming Tian, Alexander Burnett, Eric R Siegel, 2005, Virology.

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu

J. McKenney, S. Bellone, A. Santin, 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

F. Zhan, J. Shaughnessy, E. Tian, 2004, British Journal of Cancer.

Overexpression of HER-2/neu in uterine serous papillary cancer.

G. Parham, T. O'brien, S. Bellone, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Influence of Allogeneic Blood Transfusion on Clinical Outcome during Radiotherapy for Cancer of the Uterine Cervix

G. Parham, S. Bellone, A. Santin, 2003, Gynecologic and Obstetric Investigation.

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy

F. Zhan, J. Shaughnessy, S. Bellone, 2005, British Journal of Cancer.

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy

Erming Tian, F. Zhan, J. Shaughnessy, 2004, International journal of cancer.

Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector

P. Hermonat, F. Grizzi, M. Chiriva-Internati, 2001, Cancer Gene Therapy.